filmov
tv
Dr. Crawford on PSA Testing for Prostate Cancer
Показать описание
E. David Crawford, MD, professor of Radiation Oncology, University of Colorado School of Medicine, discusses challenges facing PSA testing for patients with prostate cancer.
0:02:23
Dr. Crawford on PSA Testing for Prostate Cancer
0:01:10
Dr. Crawford discusses which patients can benefit from SelectMDx testing.
0:06:45
Introduction: The AUA PSA Screening Guidelines
0:21:30
Next Generation Biomarkers: As Reflex, Combination, or First Line?
0:16:36
Early Diagnosis of Prostate Cancer: A Path Forward
0:10:37
Liquid Diagnostics and Prostate Cancer
0:09:18
Screening for Prostate Cancer: PSA: Why 1.5 is the New 4
0:11:54
Screening and Prevention of Prostate Cancer 2021 - Who Needs a Biopsy?
0:04:28
New Prostate Cancer Treatment Options
0:07:52
Early Detection of Prostate Cancer
0:48:12
Considerations to Improve Screening for Prostate Cancer
0:04:03
E. David Crawford, MD: The Benefits of ConfirmMDx
0:05:31
MRI as an Alternative to Random Needle Biopsy
0:17:33
The 'Who's' of Genomic Markers: Who to Biopsy
0:40:22
Biomarkers: PSA, 4K, or PHI?
0:02:05
What Happens If I'm Diagnosed With Prostate Cancer?
0:04:23
Who to Screen: Finding the High-Risk Prostate Cancer Patient
0:19:46
Biomarkers: A Way Forward with Prostate Cancer Early Detection
0:01:16
How should PSA screening be carried out to reduce the risk of harm to the patient
0:01:15
PSA: To Test or Not to Test for Prostate Cancer
0:01:18
Dr. Petrylak on the Role of PSA Screening in Prostate Cancer
0:03:33
Shared Decision Making for Prostate Cancer
0:01:38
Dr. Crawford discusses SelectMDx inclusion into the NCCN guidelines
0:15:48
Accurate Staging of Prostate Cancer
Комментарии